← FDA Drug Approvals (Drugs@FDA)
OLUMIANT
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2025-08-08
Drug application
- FDA Application #
ANDA217585- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OLUMIANT
- Generic name
- Baricitinib
- Active ingredients
- BARICITINIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MSN
- First approval
- 2025-08-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown